CARE TO INNOVATE

Making health products accessible to those who need them most

Latest News

By trailblazer

Driving Diagnostic Innovation in Uganda – HOLICARE

Respiratory Tract Infections (RTIs) are one of the world’s deadliest health threats, hitting the hardest in places where access to healthcare is limited. The HOLICARE project is tackling this…
By Dr Alison Wakeham

Enhancing Vineyard Health with New Methods for Detecting Grey Mould 

Grey mould may be hidden, but its impact is visible through reduced yields and compromised quality. In the latest episode of "Grower, Maker, Researcher - Wine Industry Insights," experts…
By GADx Team

5 Key Moments to Leverage Contract Research in Diagnostic Development 

Delivering a lateral flow diagnostic test to market is a huge challenge. By leveraging contract research organisations (CRO) with expertise in development we can accelerate your success. In this…
More news

Re-investing profits in global health

Radically open with intellectual property

Focus on responding to future pandemics

Support local manufacturing capacity

About Us

Global access to health innovations

A new model for innovation in health

Global Access Health is a beyond-profit biotechnology company. We’re the first to commit our profits to providing community access to affordable state-of-the-art medical technology, in particular for the Global South.

We re-invest proceeds from commercial activities to support our primary goal of expanding access to affordable, high quality diagnostics and medical solutions to underserved communities.

We focus on expanding community access beyond the clinical care setting through decentralized research, development, and manufacturing.

Read below how we are starting with diagnostics.

Our approach is radically different

Re-investing profits in global health

Find out how GAH can help you achieve your impact investing goals. We are backed by some of the best names in impact investing, and would love together with you to increase access to health innovations.

Radically open with intellectual property

We prioritize impact on end users over our bottom line, and are open to partnering with self-sustainable models.

Focus on responding to future pandemics

We develop diagnostics for emerging infectious diseases and build equitable solutions for rapid outbreak response.

Support local manufacturing capacity

We facilitate a network of production facilities and distributors to enable rapid affordable access in LMICs.

GET IN TOUCH

Get in touch with us now. Let’s explore how we can work together to strengthen community access to affordable medical technology and ensure that global health innovations reach the people that need it, everywhere.

Equitable access to high quality and affordable diagnostics and medicine for all.